MXPA04007414A - Indoles sustituidos como agonistas alfa-1. - Google Patents
Indoles sustituidos como agonistas alfa-1.Info
- Publication number
- MXPA04007414A MXPA04007414A MXPA04007414A MXPA04007414A MXPA04007414A MX PA04007414 A MXPA04007414 A MX PA04007414A MX PA04007414 A MXPA04007414 A MX PA04007414A MX PA04007414 A MXPA04007414 A MX PA04007414A MX PA04007414 A MXPA04007414 A MX PA04007414A
- Authority
- MX
- Mexico
- Prior art keywords
- alpha
- agonists
- alkyl
- compounds
- substituted indoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
La presente invencion se refiere a compuestos que son agonistas de receptores alfa-1, preferentemente agonistas de receptores alfa-1A/L, y que estan representados por la formula general(Ver formula I)en la cual X es -S(O)n- o -C(O)-, A es alquilo (C1-6), arilo, heteroarilo, hidroxialquilo (C1-6), o -(CH2)P-NRaRb, y los demas substituyentes son tal como se han definido en la memoria descriptiva; o a isomeros individuales, mezclas racemicas y no racemicas de isomeros, o sales o solvatos farmaceuticamente aceptables de los mismos. La invencion tambien se refiere a composiciones farmaceuticas que contienen dichos compuestos, a su preparacion y al empleo de las mismas como agentes terapeuticos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35350802P | 2002-02-01 | 2002-02-01 | |
US41849202P | 2002-10-15 | 2002-10-15 | |
PCT/EP2003/000644 WO2003064387A2 (en) | 2002-02-01 | 2003-01-23 | Substituted indoles as alpha-1 agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04007414A true MXPA04007414A (es) | 2004-10-11 |
Family
ID=27669110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04007414A MXPA04007414A (es) | 2002-02-01 | 2003-01-23 | Indoles sustituidos como agonistas alfa-1. |
Country Status (18)
Country | Link |
---|---|
US (1) | US6852726B2 (es) |
EP (1) | EP1501826B1 (es) |
JP (1) | JP4209332B2 (es) |
KR (1) | KR100656037B1 (es) |
CN (1) | CN100378095C (es) |
AR (1) | AR038341A1 (es) |
AT (1) | ATE340792T1 (es) |
AU (1) | AU2003218962B2 (es) |
BR (1) | BR0307406A (es) |
CA (1) | CA2473803A1 (es) |
DE (1) | DE60308670T2 (es) |
DK (1) | DK1501826T3 (es) |
ES (1) | ES2271551T3 (es) |
MX (1) | MXPA04007414A (es) |
PL (1) | PL373410A1 (es) |
PT (1) | PT1501826E (es) |
RU (1) | RU2337909C2 (es) |
WO (1) | WO2003064387A2 (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
DE60332769D1 (de) | 2002-11-07 | 2010-07-08 | Organon Nv | Indole, die sich zur behandlung von mit dem androgenrezeptor in zusammenhang stehenden krankheiten eignen |
UA79504C2 (en) * | 2002-11-07 | 2007-06-25 | Organon Nv | Indols for treating diseases associated with androgen receptors |
SE0301010D0 (sv) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
AU2004235923B2 (en) * | 2003-05-09 | 2008-01-24 | F. Hoffmann-La Roche Ag | Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists |
SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
SA04250253B1 (ar) | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن |
JP2007508363A (ja) * | 2003-10-14 | 2007-04-05 | オキサジェン リミテッド | Crth2アンタゴニスト活性を有する化合物 |
JP4448730B2 (ja) * | 2004-04-20 | 2010-04-14 | 富士フイルム株式会社 | 感光性組成物、該感光性組成物に用いられる化合物及び該感光性組成物を用いたパターン形成方法 |
TW200602317A (en) | 2004-04-23 | 2006-01-16 | Akzo Nobel Nv | Novel androgens |
GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
GB0418830D0 (en) | 2004-08-24 | 2004-09-22 | Astrazeneca Ab | Novel compounds |
EP1817282B1 (en) | 2004-11-23 | 2011-07-20 | AstraZeneca AB | Phenoxyacetic acid derivatives useful for treating respiratory diseases |
US7531568B2 (en) | 2004-11-30 | 2009-05-12 | Plexxikon, Inc. | PPAR active compounds |
EP1833787A2 (en) * | 2004-11-30 | 2007-09-19 | Plexxikon, Inc. | Indole derivatives for use as ppar active compounds |
GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
DK2839830T3 (da) * | 2005-01-14 | 2019-08-19 | Urigen Inc | Kits og sammensætninger til behandling af lidelser i de nedre urinveje |
WO2007024747A2 (en) * | 2005-08-22 | 2007-03-01 | Shell Internationale Research Maatschappij B.V. | A diesel fuel and a method of operating a diesel engine |
TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
US8148572B2 (en) | 2005-10-06 | 2012-04-03 | Astrazeneca Ab | Compounds |
NZ570528A (en) * | 2006-02-15 | 2011-09-30 | Allergan Inc | Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
CN101460458A (zh) * | 2006-02-15 | 2009-06-17 | 阿勒根公司 | 具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物 |
CN102558021A (zh) | 2006-05-26 | 2012-07-11 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
PE20090159A1 (es) | 2007-03-08 | 2009-02-21 | Plexxikon Inc | COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs |
UA100983C2 (ru) | 2007-07-05 | 2013-02-25 | Астразенека Аб | Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты |
BRPI0912355A2 (pt) * | 2008-05-05 | 2015-07-28 | Lonza Ag | Grupos de proteção de indolsulfonil para proteção dos grupamentos guanidino e amino |
EP2246326A1 (de) * | 2009-05-02 | 2010-11-03 | Bayer CropScience AG | Verfahren zur Herstellung von Oxindolen und ortho-substituierten Anilinen und ihre Verwendung als Zwischenprodukte für Synthesen |
EP2566481A4 (en) * | 2010-05-06 | 2014-01-22 | Merck Sharp & Dohme | AS FAAH MODULATORS SUITABLE AZA-INDOL DERIVATIVES |
TWI695831B (zh) * | 2014-09-13 | 2020-06-11 | 香港商南北兄弟藥業投資有限公司 | Crth2拮抗劑化合物及其用途 |
CN106674081A (zh) * | 2016-12-18 | 2017-05-17 | 南京理工大学 | 一种3‑甲硫基吲哚衍生物合成方法 |
US20220153735A1 (en) * | 2019-03-04 | 2022-05-19 | Beth Israel Deaconess Medical Center, Inc. | Orai Channel Inhibitors |
WO2022166638A1 (zh) * | 2021-02-02 | 2022-08-11 | 广东东阳光药业有限公司 | 吲哚衍生物的盐及其用途 |
WO2023183394A1 (en) * | 2022-03-24 | 2023-09-28 | Curasen Therapeutics, Inc. | Alpha 1a-adrenergic receptor agonists and methods of use |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3404156A (en) | 1966-02-23 | 1968-10-01 | Sterling Drug Inc | Imidazolin-2-yl-alkyl-substituted indoles |
US3689655A (en) | 1970-12-07 | 1972-09-05 | Sterling Drug Inc | Rodenticidal and rodent repellent compositions |
US4654360A (en) | 1984-06-01 | 1987-03-31 | Syntex (U.S.A.) Inc. | 1,2,3-trisubstituted indoles for treatment of inflammation |
US5095031A (en) | 1990-08-20 | 1992-03-10 | Abbott Laboratories | Indole derivatives which inhibit leukotriene biosynthesis |
US5334597A (en) | 1991-10-17 | 1994-08-02 | Merck Frosst Canada, Inc. | Indole carbamates as leukotriene antagonists |
ZA939516B (en) | 1992-12-22 | 1994-06-06 | Smithkline Beecham Corp | Endothelin receptor antagonists |
US6175013B1 (en) | 1994-06-10 | 2001-01-16 | Eli Lilly And Company | Imidazolinyl tachykinin receptor antagonists |
DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
FR2735774B1 (fr) | 1995-06-21 | 1997-09-12 | Sanofi Sa | Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant |
CA2203912A1 (en) | 1995-09-01 | 1997-03-13 | Dennis Michael Zimmerman | Indolyl neuropeptide y receptor antagonists |
SG72827A1 (en) * | 1997-06-23 | 2000-05-23 | Hoffmann La Roche | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
DK0924209T3 (da) | 1997-12-19 | 2003-08-25 | Lilly Co Eli | Hypoglykæmiske imidazolinforbindelser |
GB9910110D0 (en) * | 1999-04-30 | 1999-06-30 | Glaxo Group Ltd | Chemical compounds |
US6323231B1 (en) | 2000-02-17 | 2001-11-27 | Abbott Laboratories | Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence |
-
2003
- 2003-01-23 PL PL03373410A patent/PL373410A1/xx not_active Application Discontinuation
- 2003-01-23 DK DK03714714T patent/DK1501826T3/da active
- 2003-01-23 PT PT03714714T patent/PT1501826E/pt unknown
- 2003-01-23 ES ES03714714T patent/ES2271551T3/es not_active Expired - Lifetime
- 2003-01-23 KR KR1020047011902A patent/KR100656037B1/ko not_active IP Right Cessation
- 2003-01-23 JP JP2003564010A patent/JP4209332B2/ja not_active Expired - Fee Related
- 2003-01-23 RU RU2004126613/04A patent/RU2337909C2/ru not_active IP Right Cessation
- 2003-01-23 CN CNB038031841A patent/CN100378095C/zh not_active Expired - Fee Related
- 2003-01-23 AT AT03714714T patent/ATE340792T1/de active
- 2003-01-23 EP EP03714714A patent/EP1501826B1/en not_active Expired - Lifetime
- 2003-01-23 DE DE60308670T patent/DE60308670T2/de not_active Expired - Lifetime
- 2003-01-23 AU AU2003218962A patent/AU2003218962B2/en not_active Ceased
- 2003-01-23 CA CA002473803A patent/CA2473803A1/en not_active Abandoned
- 2003-01-23 BR BR0307406-4A patent/BR0307406A/pt not_active IP Right Cessation
- 2003-01-23 WO PCT/EP2003/000644 patent/WO2003064387A2/en active IP Right Grant
- 2003-01-23 MX MXPA04007414A patent/MXPA04007414A/es active IP Right Grant
- 2003-01-31 AR ARP030100287A patent/AR038341A1/es unknown
- 2003-01-31 US US10/355,588 patent/US6852726B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AR038341A1 (es) | 2005-01-12 |
CA2473803A1 (en) | 2003-08-07 |
EP1501826A2 (en) | 2005-02-02 |
WO2003064387A2 (en) | 2003-08-07 |
PT1501826E (pt) | 2007-01-31 |
CN1628113A (zh) | 2005-06-15 |
DK1501826T3 (da) | 2007-01-29 |
PL373410A1 (en) | 2005-08-22 |
US20030220319A1 (en) | 2003-11-27 |
KR100656037B1 (ko) | 2006-12-11 |
DE60308670T2 (de) | 2007-08-16 |
KR20040077927A (ko) | 2004-09-07 |
BR0307406A (pt) | 2004-12-28 |
US6852726B2 (en) | 2005-02-08 |
EP1501826B1 (en) | 2006-09-27 |
JP2005522427A (ja) | 2005-07-28 |
ATE340792T1 (de) | 2006-10-15 |
DE60308670D1 (de) | 2006-11-09 |
RU2337909C2 (ru) | 2008-11-10 |
ES2271551T3 (es) | 2007-04-16 |
WO2003064387A3 (en) | 2004-12-02 |
RU2004126613A (ru) | 2005-07-10 |
AU2003218962B2 (en) | 2008-09-25 |
JP4209332B2 (ja) | 2009-01-14 |
CN100378095C (zh) | 2008-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04007414A (es) | Indoles sustituidos como agonistas alfa-1. | |
MXPA03011244A (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6. | |
MXPA03011638A (es) | Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6. | |
NO20050016L (no) | Difenylazetidinonderivater for behandling av forstyrrelser i lipid metabolismen | |
SE0302760D0 (sv) | New compounds | |
HK1070054A1 (en) | Arylsulfonyl derivatives with5-ht6 receptor affinity | |
PA8550201A1 (es) | Analogos de prostaglandina | |
TNSN03110A1 (en) | Azaindoles. | |
PL361361A1 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
NO20062004L (no) | Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav | |
TW200630364A (en) | 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
PL361282A1 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
WO2005060959A8 (en) | Pyrazole derivatives and use thereof as orexin receptor antagonists | |
MXPA04005426A (es) | Derivados de pirazol de anillos fuisionados. | |
MXPA04005076A (es) | Derivados de 4-piperidinil alquilamina como antagonistas del receptor muscarinico. | |
MXPA04005313A (es) | Derivados de aminotetralin como antagonistas del receptor muscarinico. | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
DE602004016177D1 (de) | Methylindole und methylpyrrolopyridine als alpha-1-adrenerge agonisten | |
SE0301371D0 (sv) | New Compounds | |
EA200600022A1 (ru) | Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций | |
BRPI0415546A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios | |
RS20050426A (en) | Substituted aralkyl derivatives | |
NO20061077L (no) | Nye farnesyl-protein-transferaseinbibitorer som antitumormidler | |
SG135051A1 (en) | Azaindoles | |
ECSP993127A (es) | Derivados de dihidrobenzodioxina carboxamida y cetona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |